?. L. Approche-du-concept-d-'addiction-en-physiopathologie and H. Fernandez, Sztulman 2 http://www.inserm.fr/thematiques/neurosciences-sciences-cognitives-neurologie- psychiatrie/dossiers-d-information/addictions 3 Neurosciences : usage de substances psychoactives et dépendance, 2004.

. Drogues, chiffres clés 5 e édition ? Juin 2013 ; OFDT 8 Estimation 2011 des consommations de produits psychoactifs à 17 ans, 2012.

W. Trevor, . Robbins, J. Barry, and . Everitt, 14 Neurobehavioural mechanisms of reward and motivation, p.15

K. R. Merikangas, 23 Familial transmission of substance use disorders, Arch Gen Psychiatry, pp.973-979, 1998.

E. J. Nestler and G. K. Aghajanian, 24 Molecular and cellular basis of addiction

. Maldonado, 25 Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB, Science, 1996.

M. Kreek, 26 Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction, Nature Neuroscience, pp.8-11

M. Kreek, Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments, Pharmacological Reviews, vol.57, issue.1, pp.1-26, 2005.
DOI : 10.1124/pr.57.1.1

W. D. Hans and . Matthes, 30 Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioïd receptor gene october 1996) 31 ELK1 Transcription Factor Linked to Dysregulated Striatal Mu Opioid Receptor Signaling Network and OPRM1 Polymorphism in Human Heroïn Abusers, Nature BIOL PSYCHIATRY, vol.38374, pp.819-82331511, 2013.

C. Laforge, K. Tian, M. , M. D. Zhang, S. Borg et al., 32 Single nucleotide polymorphism in the human mu opioid receptor gene alters ?-endorphin binding and activity: possible implications for opiate addiction, 1998.

C. Szeto, N. Tang, D. Lee, and A. Stadlin, Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts, Neuroreport, vol.12, issue.6, pp.1103-1106, 2001.
DOI : 10.1097/00001756-200105080-00011

G. Bart, M. Heilig, K. Laforge, L. Pollak, S. Leal et al., Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden, Molecular Psychiatry, vol.9, issue.6, pp.547-549, 2004.
DOI : 10.1038/sj.mp.4001504

. Crowley, Psychiatric Genetics, pp.3-169, 2003.

. Glatt, Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis, Drug and Alcohol Dependence, vol.90, issue.2-3, pp.159-165, 2007.
DOI : 10.1016/j.drugalcdep.2007.02.022

. Gerra, Human Kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol.14, issue.6, pp.771-775, 2007.
DOI : 10.1002/ajmg.b.30510

/. 41-récepteurs-opioïdes-mu, . C. Delta, and . Gaveriaux-ruff, 42 Functional impact of a single nucleotide polymorphism in the OPRD1 promoter region, 2007.

D. E. Comings, 43 The proenkephalin gene (PENK) and opioid dependence

Y. Zhang, Effect of the endogenous ? opioid agonist dynorphin A(1?17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice, Psychopharmacology, vol.172, issue.4, pp.422-431, 2004.
DOI : 10.1007/s00213-003-1688-3

S. Fuke, The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression, The Pharmacogenomics Journal, vol.15, issue.2, pp.152-156, 2001.
DOI : 10.1038/sj.tpj.6500026